Screener / SEC EDGAR /CIK 0001815442 /10-K filed Feb 26, 2026, compared with Feb 27, 2025 /Numbers from the XBRL of the 10-Ks
Nasdaq Health care · Biotechnology

Kymera Therapeutics, Inc. KYMR

Compare with peers Embed
In the footnotes

What the 10-K filed Feb 26, 2026 says off the balance sheet

10-K notes
Topics with specifics 3 of 6 with a sentence that gives amounts, accruals or ratios
Sentences quoted 6 word for word, each linked to the 10-K
New this year 0 sentences with nothing like them in the 10-K filed Feb 27, 2025

Risks that are not on the face of the balance sheet. Tickdelta picks sentences with specifics and quotes them as filed. New marks a sentence with nothing like it in the 10-K filed Feb 27, 2025.

Big customers

Customers the company names as a large share of revenue or receivables (it must name any worth 10% of revenue).

No specific sentence about this in the 10-K.

Key suppliers

Parts or manufacturing that depend on one or a few suppliers.

“The drug substance and drug product in our product candidates are supplied to us from a small number of suppliers, and in some cases sole source suppliers.”

Read it in the 10-K

“We are not certain, however, that our single-source and dual source suppliers will be able to meet our demand for their products.”

Read it in the 10-K

“Because we do not anticipate paying any cash dividends on our capital stock in the foreseeable future, capital appreciation, if any, will be investors’ sole source of gain.”

Read it in the 10-K

“As a result, capital appreciation, if any, of our common stock will be investors’ sole source of gain for the foreseeable future.”

Read it in the 10-K

Lawsuits and legal claims

Pending cases, settlements and what the company has set aside for them.

“Regardless of outcome, litigation can have an adverse impact on our business, financial condition, results of operations and prospects because of defense and settlement costs, diversion of management resources and other factors.”

Read it in the 10-K

Guarantees and indemnities

Promises to pay someone else's debts or losses if they cannot.

“The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited.”

Read it in the 10-K

Debt covenants

Conditions in loan agreements that, if broken, can make debt due early.

No specific sentence about this in the 10-K.

Commitments off the balance sheet

Contracts the company must pay for later: purchase obligations, take-or-pay deals.

No specific sentence about this in the 10-K.

Customers it names 0 tracked companies its filings call a customer
Suppliers it names 0 tracked companies its filings call a supplier
Companies that name it 0 tracked companies whose filings call it a customer or a supplier

Companies it names

Tracked companies that its latest 10-K or its 8-Ks of the last year call a customer or a supplier.

No other tracked company is named as a customer or a supplier in the latest filings.

Companies that name it

Tracked companies whose latest 10-K or 8-Ks call it a customer or a supplier.

No other tracked company names it as a customer or a supplier in the latest filings.

Sentences are chosen by their words, not read by AI, so some can be off topic. Always check the filing. Open the 10-K

Sources

The notes to the financial statements, Legal Proceedings and the MD&A of the latest 10-K (and, for customers and suppliers, Business and Risk Factors), quoted as filed.

Also

Debt: the debt note in numbers.

Work with it

Excel workbook · CSV. Google Sheet that stays up to date: paste =IMPORTDATA("https://tickdelta.com/company/KYMR/export.csv") into a cell.

Next:Reverse DCF
Esc

Type a ticker such as AAPL, a name, an investor such as Buffett, or a topic such as tariffs. ↑ ↓ to move, Enter to open.